High Blood Viscosity in Dogs (Hyperviscosity Syndrome)
- Occurrence: rarer
- Location of disease: General/Whole body
When to visit the vet?
Urgent see a veterinarian within 24 hours
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
Hyperviscosity syndrome in dogs is characterized by increased blood viscosity, usually due to high plasma protein content. This thickening of the blood impairs normal blood flow and can lead to a variety of clinical problems.
The most important facts at a glance
Hyperviscosity syndrome in dogs is a disease in which the blood becomes thicker due to high plasma protein content, especially immunoglobulins. This increased viscosity can impair blood flow and lead to various health problems. The main cause is often excessive antibody production by diseases such as lymphomas or plasmacytomas. Chronic inflammatory conditions and infections can also increase plasma protein levels.
Typical symptoms include loss of appetite, weakness, increased thirst and urination, bleeding tendencies, and breathing problems. In severe cases, seizures, nosebleeds, and visual disturbances may occur. For diagnosis, blood tests are performed to check protein concentration, as well as imaging procedures to detect tumors or organ enlargements.
Treatment focuses on combating the underlying disease, often through surgical procedures, radiation therapy, or chemotherapy. In acute cases, plasmapheresis may be necessary to remove excess proteins. Medications such as corticosteroids can also be used to reduce inflammation and modulate the immune response.
The prognosis depends on the underlying cause. With successful treatment of the underlying disease, blood viscosity can normalize. There are no direct preventive measures, but regular veterinary examinations and a healthy lifestyle can help minimize risks. Research focuses on developing new diagnostic and treatment methods as well as understanding the causes of this disease.
Causes
Blood viscosity refers to the thickness and stickiness of blood, which is crucial for smooth blood flow through the vessels. In dogs affected by hyperviscosity syndrome, this viscosity is increased, often caused by excessive production of plasma proteins such as immunoglobulins. These proteins can accumulate in the blood for various reasons.
One of the main causes of hyperviscosity syndrome is the excessive production of antibodies, which is often associated with certain cancers such as lymphomas or plasmacytomas. These diseases lead to an abnormally high number of plasma cells that produce large amounts of antibodies, which increase blood viscosity.
Furthermore, chronic inflammatory conditions and infections can also lead to an increase in plasma proteins. Infections that place heavy demands on the immune system can stimulate excessive protein production to protect the body, which in turn increases blood viscosity.
Symptoms
The symptoms of Hyperviscosity Syndrome in dogs can vary widely and often depend on the underlying cause and the degree of viscosity increase. The most common signs include Lethargy and weakness, caused by reduced oxygen supply to the tissues.
Other symptoms may include neurological problems such as Seizures or Behavioral changes, which result from insufficient blood flow to the brain. Nosebleeds or Bleeding gums are also common, as the increased viscosity can lead to vascular damage.
Additionally, enlargement of the lymph nodes or spleen may occur. These symptoms are often the result of the underlying disease causing hyperviscosity syndrome, such as lymphoma.
Therapy
Treatment of hyperviscosity syndrome aims to address the underlying cause and relieve symptoms. If a tumor is the cause, surgical procedures, radiation therapy, or chemotherapy may be considered to reduce tumor mass and decrease plasma protein production.
Plasmapheresis can be used in acute cases to remove excess proteins from the blood and quickly lower viscosity. This technique can be lifesaving, especially in dogs with severe neurological symptoms.
Additionally, medications such as corticosteroids can be used to reduce inflammation and modulate the immune response. These medications help decrease plasma protein production and normalize blood viscosity.
Prognosis and follow-up care
The prognosis for dogs with hyperviscosity syndrome depends heavily on the underlying cause. With successful treatment of the underlying disease, such as tumor removal, blood viscosity can normalize and the dog can lead a normal life.
However, if the underlying disease is chronic or incurable, as may be the case with some cancers, the prognosis is often more guarded. The dog’s quality of life can be improved through symptomatic treatment and management, but the long-term prognosis depends on the specific disease and its aggressiveness.
Prevention
Since hyperviscosity syndrome is often associated with cancers and chronic inflammatory conditions, there are no specific preventive measures that can completely prevent the syndrome. However, regular veterinary examinations are crucial to detect and treat potential problems early.
A balanced diet and healthy lifestyle can strengthen the immune system and reduce the risk of infections and chronic inflammatory conditions. Furthermore, it is important to minimize known risk factors for cancers by being mindful of environmental toxins and harmful substances.
Owners should watch for changes in their dog’s behavior or health and consult a veterinarian for unusual symptoms to diagnose and treat potential conditions early.
Outlook on current research
Hyperviscosity syndrome in dogs is a complex disease characterized by high plasma protein content in the blood. This increase in proteins can raise the viscosity or thickness of the blood, leading to a range of health challenges. Current research focuses on understanding the exact mechanisms that lead to this disease, as well as developing new diagnostic and treatment methods.
A significant part of the research involves investigating the causes of increased plasma protein production. Genetic factors play a role here, but also environmental factors and the presence of certain diseases, such as immune system tumors, which can lead to an increase in immunoglobulins. Researchers are also investigating how hyperviscosity syndrome interacts with other diseases and what role it plays in worsening symptoms.
Another area of research focuses on optimizing diagnostic tests. Traditionally, diagnosis is made through blood tests that measure blood viscosity and determine protein content. However, new technological advances enable more accurate and faster diagnoses that are less invasive and allow for quicker treatment.
In therapy development, new medications and treatment approaches are currently being tested that can reduce plasma protein production or alleviate the symptoms of the syndrome. These new approaches aim to improve the quality of life of affected dogs and optimize prognosis.
In the long term, researchers hope to create a more comprehensive understanding base that will make it possible to develop preventive measures. These could help reduce the risk of developing Hyperviscosity Syndrome or mitigate its course before it leads to serious health problems.
Frequently Asked Questions (FAQs)
1. What is hyperviscosity syndrome in dogs?
2. What are the Symptoms: of a dog with hyperviscosity syndrome?
3. How is hyperviscosity syndrome diagnosed?
4. What causes can lead to hyperviscosity syndrome?
5. Can hyperviscosity syndrome be treated?
6. What risks are associated with hyperviscosity syndrome?
7. How common is hyperviscosity syndrome in dogs?
8. Are there preventive measures for hyperviscosity syndrome?
9. What is the prognosis for dogs with hyperviscosity syndrome?
10. Are there special dietary recommendations for dogs with hyperviscosity syndrome?
Literature
- Francey, T., & Schweighauser, A. (2019). Membrane-based therapeutic plasma exchange in dogs: Prescription, anticoagulation, and metabolic response. Journal of Veterinary Internal Medicine, 33(4), 1635–1645. https://doi.org/10.1111/jvim.15528
- Lippi, I., Perondi, F., Ross, S. J., Marchetti, V., Lubas, G., & Guidi, G. (2015). Double filtration plasmapheresis in a dog with multiple myeloma and hyperviscosity syndrome. Open Veterinary Journal, 5(2), 108–112. https://doi.org/10.5455/OVJ.2015.v5.i2.p108
- Matus, R. E., Leifer, C. E., Gordon, B. R., MacEwen, E. G., & Hurvitz, A. I. (1983). Plasmapheresis and chemotherapy of hyperviscosity syndrome associated with monoclonal gammopathy in the dog. Journal of the American Veterinary Medical Association, 183(2), 215–218.
- Hurvitz, A. I., Haskins, S. C., & Fischer, C. A. (1970). Macroglobulinemia with hyperviscosity syndrome in a dog. Journal of the American Veterinary Medical Association, 157(4), 455–460.
- MacEwen, E. G., Hurvitz, A. I., & Hayes, A. (1977). Hyperviscosity syndrome associated with lymphocytic leukemia in three dogs. Journal of the American Veterinary Medical Association, 170(11), 1309–1312.
- Proverbio, D., Spada, E., Perego, R., & de Giorgi, G. B. (2016). Seizures as a consequence of hyperviscosity syndrome in two dogs naturally infected with Leishmania infantum. Journal of the American Animal Hospital Association, 52(2), 119–123. https://doi.org/10.5326/JAAHA-MS-6240
- Hoskins, J. D., Barta, O., & Rothschmitt, J. (1983). Serum hyperviscosity syndrome associated with Ehrlichia canis infection in a dog. Journal of the American Veterinary Medical Association, 183(9), 1011–1012.
- Giraudel, J. M., Pagès, J.-P., & Guelfi, J.-F. (2002). Monoclonal gammopathies in the dog: A retrospective study of 18 cases (1986–1999) and literature review. Journal of the American Animal Hospital Association, 38(2), 135–147. https://doi.org/10.5326/0380135
- Tabar, M.-D., Maggi, R. G., Altet, L., Vilafranca, M., Francino, O., & Roura, X. (2011). Gammopathy in a Spanish dog infected with Bartonella henselae. Journal of Small Animal Practice, 52(4), 209–212. https://doi.org/10.1111/j.1748-5827.2011.01046.x
- Kato, H., Momoi, Y., Omori, K., Youn, H.-Y., Yamada, T., Goto, N., Ono, K., Watari, T., Tsujimoto, H., & Hasegawa, A. (1995). Gammopathy with two M-components in a dog with IgA-type multiple myeloma. Veterinary Immunology and Immunopathology, 49(1–2), 161–168. https://doi.org/10.1016/0165-2427(95)05462-f